Ferritin-ApoE nanocarrier for targeted therapy of neuromyelitis optica spectrum disorder in mice. [PDF]
Zhao X +13 more
europepmc +1 more source
Functional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. [PDF]
Leveraro E +11 more
europepmc +1 more source
Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder. [PDF]
Tsuzaki K +5 more
europepmc +1 more source
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan. [PDF]
Fujihara K +6 more
europepmc +1 more source
Anti-nuclear antibodies in patients with suspicion of neuromyelitis optica spectrum disorder: Frequency and significance. [PDF]
Jalil F, Sheikh S, Ahmad A, Ahmed TA.
europepmc +1 more source
Apathy in patients with Neuromyelitis Optica Spectrum Disorder. [PDF]
He Z +6 more
europepmc +1 more source
Pediatric neuromyelitis optica spectrum disorder
Aman Mehta
doaj +1 more source
AQP4 antibody-induced astrocyte injury reshapes CNS immune architecture in a combined EAE-AQP4-IgG model of neuromyelitis optica spectrum disorder. [PDF]
Hyun D +9 more
europepmc +1 more source
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder. [PDF]
Gonzalez Manrique P +3 more
europepmc +1 more source

